Fusion protein technologies for biopharmaceuticals : applications and challenges /
The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Hoboken, New Jersey :
John Wiley & Sons,
[2013]
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Table of Contents:
- pt. 1. Introduction
- pt. 2. The triple t paradigm : time, toxin, targeting
- pt. 3. Beyond the triple t-paradigm.